Psychiatry and Neurology, Neurology · Ormond Beach, FL
NPI
1508863572
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
725 W Granada Blvd, Suite 22
Ormond Beach, FL, 32174
Phone (386) 788-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$646K
10,159 services
Medicare patients, 2024
545
Average age 70
Drug cost, 2024
$1.9M
11,153 prescriptions
Company payments, 2025
$2,312
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alyn L Benezette was code 99214 (office e&m - established), 2,559 times for 466 patients. In total Alyn L Benezette billed 10,159 services in 48 codes, and Medicare paid $646K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,559 | 466 | $87.04 | $223K |
| 80307 Drug Tests | Office | 2,443 | 377 | $60.73 | $148K |
| 96136 Behavioral Health Services | Office | 1,369 | 295 | $29.99 | $41K |
| 96132 Behavioral Health Services | Office | 733 | 281 | $95.63 | $70K |
| 96130 Behavioral Health Services | Office | 732 | 281 | $89.79 | $66K |
| 96138 Behavioral Health Services | Office | 599 | 264 | $25.06 | $15K |
| 97110 PT Treatment | Office | 357 | 23 | $16.72 | $5,968 |
| 99213 Office E&M - Established | Office | 282 | 119 | $68.42 | $19K |
| G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 122 | 91 | $19.89 | $2,427 |
| 95923 Electrical Nerve Conductivity | Office | 106 | 106 | $85.81 | $9,096 |
| 95921 Electrical Nerve Conductivity | Office | 106 | 106 | $64.89 | $6,879 |
| 93923 Duplex Scan - Extremity Arteries | Office | 99 | 98 | $94.21 | $9,326 |
| 99215 Office E&M - Established | Office | 69 | 61 | $127.37 | $8,788 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 51 | 41 | $15.80 | $806 |
| 92540 Vision, Hearing, and Speech Services | Office | 28 | 28 | $79.60 | $2,229 |
By year: 2022 $717K for 10,331 services; 2023 $808K for 12,907 services; 2024 $646K for 10,159 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 2,443 | 377 | $60.73 | $148K |
Medicare prescription drug claims, 2024
In 2024, the drug Alyn L Benezette prescribed most often to Medicare patients was Oxycodone Hcl, with 1,551 prescriptions and refills. In total Alyn L Benezette wrote 11,153 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,551 | 1,570 | 208 | $39K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,301 | 1,358 | 216 | $50K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 903 | 903 | 144 | $39K |
| Morphine Sulfate Er Morphine Sulfate | 656 | 672 | 80 | $22K |
| Gabapentin Generic | 574 | 735 | 131 | $9,921 |
| Tizanidine Hcl Generic | 425 | 565 | 94 | $4,805 |
| Pregabalin Generic | 425 | 492 | 76 | $11K |
| Morphine Sulfate Generic | 226 | 228 | 30 | $6,832 |
| Cyclobenzaprine Hcl Generic | 219 | 273 | 55 | $3,007 |
| Xtampza Er Oxycodone Myristate | 207 | 211 | 30 | $306K |
| Alprazolam Generic | 202 | 214 | 25 | $1,078 |
| Carisoprodol Generic | 192 | 192 | 25 | $2,544 |
| Duloxetine Hcl Generic | 178 | 266 | 37 | $1,806 |
| Baclofen Generic | 150 | 186 | 38 | $2,071 |
| Oxycontin Oxycodone Hcl | 142 | 142 | 18 | $198K |
Brand drugs: 1,093 claims; generic drugs: 10,043 claims; opioid claims: 5,432.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alyn L Benezette $2,312 ($2,312 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $617.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $617 |
| Pfizer Inc. PFE | 21 | $389 |
| Protega Pharmaceutials Inc | 4 | $267 |
| Eisai Inc. 4523.T | 8 | $201 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $153 |
| UCB, Inc. UCB.BR | 4 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $106 |
| Argenx US, Inc. ARGX | 2 | $67.44 |
| EMD Serono, Inc. MRK.DE | 2 | $47.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.